TNON Company Profile and Key Details

Tenon Medical, Inc. has 8.88 million shares outstanding. The public float is 8.23 million shares, elevated short interest at 7.19% of float. This equals 636.50 thousand shares. The short ratio is 0.06 days. Institutional investors hold 4.43% of the float. Insiders own 13.76%. Grawey Nathaniel A. holds 101.17 thousand shares, VAN DICK STEVEN M has 100.42 thousand shares and GINN RICHARD has 85.32 thousand shares. Over the past six months, insider transactions show net buying. They sold 0.00 shares across 0 transactions.

TNON has shown mixed momentum, gaining 1.88% over the past week and -21.69% over the past quarter, though year-to-date performance is up 2.05%. Short-term trend indicators are bullishly aligned (SMA20 8.17%, SMA50 -6.62%, SMA200 -21.89%). The stock’s 14-day RSI is 51.56 (neutral), while the ATR of 0.07 points to higher daily volatility. The stock remains hovering near 52-week lows, trading -85.35% below its high and over 33.68% above its low. Average 10-day trading volume of 26.92 thousand shares is below the 3-month average of 1.01 million, indicating normal recent market interest.

Tenon Medical, Inc. generated EPS of -$2.76 over the past year. Five-year average earnings growth is -25.43%. Wall Street analysts project EPS growth of 59.74% annually over the next five years. The latest quarter delivered EPS of -$0.22. The next quarter is forecast at -$0.36. Next year's EPS is expected at $62.98. Tenon Medical, Inc. earnings surprise history is a mixed track record. The quarter that ended March 19, 2026, missed forecasts by -38.89%. The prior quarter beat by 29.03%. Over the last six quarters, Apple has recorded several small beats. These include -14.39% in November 13, 2024.

Dividend and splits history remains an important factor for investors monitoring long-term returns.

Tenon Medical, Inc. (NASDAQ:TNON) closed at $0.78 USD, gaining $0.02 (2.40%) from the previous close of $0.76. The stock is currently mid-range between its 52-week high and low $0.64 and $2.48. With a market capitalization of about $5.78 million, Tenon Medical, Inc. is classified as a micro-cap and shows market-like volatility (beta ~1.25). Key stats such as the average daily volume over the past year has been around 1.05 million shares, volume is running light vs its 52-week average. Headquartered in Los Gatos, CA, Tenon Medical, Inc. operates in the Healthcare sector and the Medical - Devices industry. Led by CEO Steven Foster, the company employs approximately 27 people and listed since April 27, 2022. Tenon Medical, Inc., a medical device company, develops surgical implant systems to optimize sacroiliac joint fixation/fusion surgery and corresponding outcomes.

Tenon Medical, Inc. trades at a P/E ratio of -0.68, slightly below the S&P 500 average, with a price-to-sales ratio of 1.46 and a price-to-book ratio of 1.68 suggesting the stock is closer to book value. The P/FCF stands at -0.52, also above market averages.

Tenon Medical, Inc. (NASDAQ:TNON) shares are flat 2.05% year-to-date currently trading near 52-week highs band. Short-term momentum has been negative over the last quarter, despite recent volatility. Valuation shows Tenon Medical, Inc. trading at a premium to the broader market with a P/E of -0.68. Analyst sentiment is bullish, with the majority of ratings in Buy territory and a mean price target of $5.00, suggesting 554.45% upside. Our AI forecast model points to short-term strength (3.4% over two weeks), a medium-term rise (11.26% over three months), and a longer-term loss (-86.91% over one year), with expected trading ranges indicating moderate volatility.

Our AI price prediction model suggests that Tenon Medical, Inc. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected increase of 3.4%, with price expected at $0.79 by May 14, 2026, within a range of $0.75 to $0.84 3-Month Outlook: Projected rise of 11.26%, reaching $0.85 by July 29, 2026, with a range of $0.74 to $0.94. 1-Year Outlook: Projected loss of -86.91%, with price at $0.10 by April 30, 2027, within a range of $0.00 to $1.55.